NOTICE & PROXY STATEMENT MEETING AUGUST 6, 2002

Company

Oruka Therapeutics, Inc.

Filed

June 13, 2002

Period of Report

August 6, 2002

Accession Number

0000891618-02-002811

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →